Can Prenatal Testing in the First Trimester be Performed without Ultrasound?

E. Merz

doi:10.1055/s-0043-102832

Ultraschall in der Medizin - European Journal of Ultrasound, Inhaltsverzeichnis

Ultraschall Med 2017; 38(02): 126-128
DOI: 10.1055/s-0043-102832

Editorial

Can Prenatal Testing in the First Trimester be Performed without Ultrasound?

Pränatale Diagnostik im I. Trimenon – ohne Ultraschall?

Authors

E. Merz

Abstract

Volltext

Referenzen

References
1 Lo YMD. Corbetta N. Chamberlain PF. et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487
2 Bianchi DW. Parker RL. Wentworth J. et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl JMed 2014; 370: 799-808
3 Schmid M. Klaritsch P. Arzt W. et al. Cell-free DNA testing for fetal chromosomal anomalies in clinical practice: Austrian-German-Swiss recommend-dations for non-invasive prenatal tests (NIPT). Ultraschall in Med 2015; 36: 507-510
4 Eiben B. Krapp M. Borth H. et al. Single Nucleotide Polymorphism-Based Analysis of Cell-Free Fetal DNA in 3000 Cases from Germany and Austria. Ultrasound International Open 2015; 1: E8-E11
5 Taylor-Phillips S. Freeman K. Geppert J. et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ Open 2016; 6: e010002
6 Mackie FL. Hemming K. Allen S. et al. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. BJOG 2017; 124: 32-46
7 Gil MM. Quezada MS. Revello R. et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 249-266
8 Gross SJ. Stosic M. McDonald-McGinn DM. et al. Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome. Ultrasound Obstet Gynecol 2016; 47: 177-183
9 Jia Y. Zhao H. Shi D. et al. Genetic effects of a 13q31.1 microdeletion detected by noninvasive prenatal testing (NIPT). Int J Clin Exp Pathol 2014; 7: 7003-7011
10 Long AA. Abuhamad AZ. Warsof SL. Modifying risk of aneuploidy with a positive cell-free fetal DNA result. Clin Lab Med 2016; 36: 249-259
11 Nicolaides KH. Spencer K. Avgidou K. et al. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226
12 Kagan KO. Hoopmann M. Hammer R. et al. Screening for chromosomal abnormalities by first trimester combined screening and noninvasive prenatal testing. Ultraschall in Med 2015; 36: 40-46
13 Merz E. Thode C. Eiben B. et al. Prenatal Risk Calculation (PRC) 3.0: An Extended DoE-Based First-Trimester Screening Algorithm Allowing For Early Blood Sampling. Ultrasound Int Open 2016; 2: E19-E26 . Epub 2016 Feb 23
14 von Kaisenberg C. Chaoui R. Häusler M. et al. Quality Requirements for the early Fetal Ultrasound assessment at 11–13+6 weeks of gestation (DEGUM Levels II and III). Ultraschall in Med 2016; 37: 297-302
15 Dugo N. Padula F. Mobili L. et al. Six consecutive false positive cases from cell-free fetal DNA testing in a single referring centre. J Prenat Med 2014; 8: 31-35
16 Van Opstal D. Srebniak MI. Cytogenetic confirmation of a positive NIPT result: evidence-based choice between chorionic villus sampling and amniocentesis depending on chromosome aberration. Expert Rev Mol Diagn 2016; 16: 513-520
17 Van Opstal D. Srebniak MI. Polak J. et al. False negative NIPT results: risk figures for chromosomes 13, 18 and 21 base on chorionic villi results in 5967 cases and literature review. PLOS one
18 Ashoor G. Syngelaki A. Poon LC. et al. Fetal fraction in maternal plasma cell-free DNA at 11–13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013; 41: 26-32
19 Yaron Y. The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon. Prenat Diagn 2016; 36: 391-396
20 Wiesel A. Stolz G. Queisser-Wahrendorf A. Fehlbildungen: Häufigkeiten und Risiko-faktoren. Aktuelle Daten aus dem Geburtenregister Mainzer Modell (MaMo). Kinder- und Jugendarzt 2016; 10: 688-672
21 ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. Ultrasound Obstet Gynecol 2014; 44: 122-123
22 Bromley B. Shipp TD. Lyons J. et al. Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy. J Ultrasound Med 2014; 33: 1737-1745
23 Rossi AC. Prefumo F. Accuracy of ultrasonography at 11–14 weeks of gestation for detection of fetal structural anomalies: a systematic review. Obstet Gynecol 2013; 122: 1160-1167
24 Rempen A. Chaoui R. Häusler M. et al. Quality requirements for ultrasound examination in early pregnancy (DEGUM Level I) between 4+0 and 13+6 weeks of gestation. DEGUM Level III Group Recommendations of the Section Obstetrics and Gynecology, Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM). Ultraschall in Med 2016; 37: 579-583
25 Merz E. Eichhorn KH. von Kaisenberg C. et al. Arbeitsgruppe der DEGUM-Stufe III. Updated quality requirements regarding secondary differentiated ultrasound exami-nation in prenatal diagnostics (= DEGUM Level II) in the period from 18 + 0 to 21 + 6 weeks of gestation. Ultraschall in Med 2012; 33: 593-596